Multiple Ascending Dose Study of LY4256984 in Participants with Sporadic Amyotrophic Lateral Sclerosis
J6I-MC-OWAA
Phase 1 other active
Quick answer
Multiple Ascending Dose Study of LY4256984 in Participants with Sporadic Amyotrophic Lateral Sclerosis for Sporadic Amyotrophic Lateral Sclerosis is a Phase 1 program (other) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Sporadic Amyotrophic Lateral Sclerosis
- Phase
- Phase 1
- Modality
- other
- Status
- active